ECG recorder suitable for early arrhythmia screening, chronic disease and daily ECG monitoring of postoperative patients has been launched. As long as you wear a thin and non-sensing ECG recorder on your chest, you can realize continuous collection of human ECG signals, providing screening for early detection, early diagnosis, early treatment of heart diseases such as atrial fibrillation, and timely corresponding intervention.
Relying on the company’s technical accumulation in time frequency and application fields for many years, combined with modern electronic information technology, the team has developed a remote closed-loop ECG monitoring system based on “user-end sensing , data transmission and storage , AI interpretation service”. The electrical recorder realizes long-term continuous dynamic monitoring of human ECG signals. The ECG data is processed by the AI interpretation platform to complete the ECG signal quality assessment, rapid positioning of abnormal ECG segments, detection of common arrhythmias, and heart rate variability. Sex analysis and other functions, form an ECG analysis report, make timely warnings for possible mutations, and provide important evidence for users when seeking medical treatment. As a medical-grade ECG monitoring product that is almost non-inductive, it is only the diameter of a watch and has no lead wires. Users can stick it with them wherever they go. Sleeping at night will not affect sleep, and it can also monitor ECG continuously when showering.
The main clinical application scenarios of long-term ECG monitoring are: (1) Detecting hidden and transient arrhythmias: occasional palpitation and palpitations. (2) Atrial fibrillation screening, follow-up after interventional surgery, follow-up, evaluation of curative effect, and adjustment of treatment plan. (3) Stroke/transient ischemic attack, high risk of stroke population. (4) Unexplained syncope. (5) Surveillance of high-risk groups and high-risk groups of cardiovascular disease. (6) Monitoring of special populations and sub-healthy populations.
The longer the ECG monitoring time, the higher the detection rate of arrhythmia. For transient and occasional arrhythmias, it is difficult to capture abnormal ECG segments on a one-time Holter monitor because of their short onset time and infrequent onset.
Stroke has become an important disease endangering the life and health of middle-aged and elderly people in my country, and 15%-40% of stroke patients are caused by atrial fibrillation. Atrial fibrillation is detected after 48 hours, so for stroke patients, ECG monitoring should be more than 48 hours. The etiological diagnosis of syncope is mainly confirmed by conventional electrocardiogram, 24-hour Holter and upright tilt test, but the diagnosis rate of syncope by the three methods is low, 39% for conventional ECG and 35% for upright tilt test. The detection rate of ECG for new-onset atrial fibrillation screening is 2%-5%, and the detection rate of Holter monitoring is 2%-6%, and the detection rate of atrial fibrillation is seriously underestimated.
Therefore, at least one week of detection time can better improve the detection rate of atrial fibrillation. New intelligent monitoring equipment with ECG monitoring function: Long-term ECG monitoring can be performed on patients after radiofrequency ablation of atrial fibrillation, and whether atrial fibrillation has recurred can be assessed.
The value of long-term ECG monitoring: long monitoring time; high detection rate; high accuracy; early and timely. Application of long-term ECG monitoring: arrhythmia; atrial fibrillation; stroke, transient ischemic attack, unexplained syncope, monitoring of special populations.
Español 
English